Patent · US Active

Circulating miRNAs as biomarkers for diagnosis of mild cognitive impairment and Alzheimer's disease

US12054779B2 · kind B2 · utility

0Cited by

0References

8Claims

0Family size

Assignees

UNIVERSITAT AUTÓNOMA DE BARCELONA · ES
Centro Investigacion Biomedica En Red Enfermedades Neurodegenerativas (CIBERNED) · ES

Inventors

Alfredo Jesus Miñano Molina · Bellaterra, ES
Dolores Siedlecki Wullich · Bellaterra, ES
Jose Rodriguez Alvarez · Bellaterra, ES

Key dates

Filing date	Jun 13, 2019
Grant date	Aug 6, 2024
Priority date	—
Expiry date	Dec 3, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/178
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The invention relates to a specific panel of circulating synaptic protein related miRNAs for use in the diagnosis of Mild Cognitive Impairment (MCI) and/or early diagnosis of Alzheimer's disease (AD). The invention also relates to a method and to a kit for the diagnosis of said diseases using said specific panel of circulating miRNAs biomarkers.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.